{"id":"https://openalex.org/W2063922073","doi":"https://doi.org/10.1055/s-2003-39237","title":"Metabolic Effects of Mealtime Insulin Lispro in Comparison to Glibenclamide in Early Type 2 Diabetes","display_name":"Metabolic Effects of Mealtime Insulin Lispro in Comparison to Glibenclamide in Early Type 2 Diabetes","publication_year":2003,"publication_date":"2003-05-14","ids":{"openalex":"https://openalex.org/W2063922073","doi":"https://doi.org/10.1055/s-2003-39237","mag":"2063922073","pmid":"https://pubmed.ncbi.nlm.nih.gov/12746761"},"language":"en","primary_location":{"id":"doi:10.1055/s-2003-39237","doi":"https://doi.org/10.1055/s-2003-39237","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2003-39237","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology &amp; Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044778195","display_name":"Thomas M. Forst","orcid":"https://orcid.org/0000-0003-2132-5691","observed_orcids":["https://orcid.org/0000-0003-2132-5691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Forst","raw_affiliation_strings":["Institute for Clinical Research and Development, Mainz, Germany. Thomasf@ikfe.de","Institute for Clinical Research and Development, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Clinical Research and Development, Mainz, Germany. Thomasf@ikfe.de","institution_ids":[]},{"raw_affiliation_string":"Institute for Clinical Research and Development, Mainz, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051325771","display_name":"J Eriksson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Eriksson","raw_affiliation_strings":["Metabolenheten - Medicinkliniken, Ume\u00e5, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolenheten - Medicinkliniken, Ume\u00e5, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037824757","display_name":"Hermann-Josef Strotmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.-J. Strotmann","raw_affiliation_strings":["Center for Diabetes and Nutritional Medicine, Rotenburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Diabetes and Nutritional Medicine, Rotenburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Bai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Bai","raw_affiliation_strings":["Eli Lilly & Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068141665","display_name":"Rocco L. Brunelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Brunelle","raw_affiliation_strings":["Eli Lilly & Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109176630","display_name":"K. S. Gulliya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Gulliya","raw_affiliation_strings":["Eli Lilly & Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087141879","display_name":"Sabine Gack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Gack","raw_affiliation_strings":["Eli Lilly & Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089958204","display_name":"Uwe Gudat","orcid":"https://orcid.org/0000-0002-6954-6904","observed_orcids":["https://orcid.org/0000-0002-6954-6904"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U. Gudat","raw_affiliation_strings":["Eli Lilly & Company, Indianapolis, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Company, Indianapolis, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2032,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.62157054,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"111","issue":"02","first_page":"97","last_page":"103"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.9559999704360962},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/early-type-2-diabetes","display_name":"early type 2 diabetes","score":0.949999988079071},{"id":"https://openalex.org/keywords/glycemic-excursions","display_name":"glycemic excursions","score":0.7960000038146973},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.8650000095367432},{"id":"https://openalex.org/keywords/proinsulin","display_name":"proinsulin","score":0.8989999890327454},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.40400001406669617},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6570000052452087},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9100000262260437},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7360000014305115},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.7450000047683716},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.4000000059604645},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.5139999985694885},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8466704487800598},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.8343038558959961},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.791300892829895},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7296872138977051},{"id":"https://openalex.org/C90061646","wikidata":"https://www.wikidata.org/wiki/Q426173","display_name":"Proinsulin","level":3,"score":0.6967653036117554},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.6769716143608093},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6683323383331299},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6058233976364136},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5992052555084229},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.47076964378356934}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004435","descriptor_name":"Eating","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017668","descriptor_name":"Age of Onset","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2003-39237","doi":"https://doi.org/10.1055/s-2003-39237","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2003-39237","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology &amp; Diabetes","raw_type":"journal-article"},{"id":"pmid:12746761","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12746761","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1997718308","https://openalex.org/W1983011824","https://openalex.org/W2225703314","https://openalex.org/W3098322108","https://openalex.org/W2165916704","https://openalex.org/W2155787946","https://openalex.org/W2170236727","https://openalex.org/W2421182246","https://openalex.org/W2089835490","https://openalex.org/W2885332001"],"abstract_inverted_index":{"The":[0],"efficacy":[1],"and":[2,77,113,137,164,193,222,246,253,308,320],"safety":[3],"of":[4,8,17,39,71,91,298,316],"the":[5,14,161,176,262,270],"preprandial":[6,48],"injection":[7],"insulin":[9,49,194,318],"lispro":[10,50],"was":[11,239,267,300],"compared":[12],"with":[13,21,33,272,278,302],"oral":[15],"administration":[16],"glibenclamide":[18,53],"in":[19,37,160,175,188,258,305],"patients":[20,32,59,79],"early":[22],"type":[23],"2":[24],"diabetes.":[25],"In":[26,295],"this":[27],"open-label,":[28],"multicenter":[29],"study,":[30],"143":[31],"a":[34,303,312],"glucagon-stimulated":[35],"increase":[36],"C-peptide":[38,190,307],"at":[40,237],"least":[41],"0.4":[42,201],"nmol/L":[43],"were":[44,106,130,197],"randomized":[45],"to":[46,67,87,155,170,186,274],"receive":[47],"(LP)":[51],"or":[52,292],"(GB)":[54],"for":[55,111,118,135,142,244,251],"26":[56],"weeks.":[57],"Seventy-five":[58],"received":[60,80],"LP":[61,112,136,162,179,245,279,299],"(51":[62],"male/24":[63],"female;":[64,84],"age":[65,85],"40":[66],"70":[68,88],"years,":[69],"duration":[70,90],"diabetes":[72,92],"4.4":[73],"+/-":[74,94,108,115,132,139,153,157,168,172,200,205,212,217,225,230,241,248],"2.9":[75],"years)":[76],"68":[78],"GB":[81,119,143,177,181,252,287],"(39":[82],"male/29":[83],"39":[86],"years;":[89],"4.3":[93],"3.4":[95],"years).":[96],"After":[97,123],"12":[98],"weeks,":[99,125],"mean":[100,126],"90":[101],"minute":[102],"blood":[103,127,282],"glucose":[104,128,283],"excursions":[105,129],"0.9":[107],"1.0":[109,131,242],"mmol/L":[110,117,134,141],"1.8":[114],"1.2":[116,140,249],"(p":[120,144,207,219],"<":[121],"0.0001).":[122],"24":[124],"1.1":[133,216],"1.7":[138],"=":[145,208,220],"0.002).":[146],"Body":[147],"weight":[148,291],"decreased":[149],"slightly":[150],"from":[151,166,184],"87.2":[152],"2.3":[154],"86.5":[156],"12.2":[158],"kg":[159,174],"group":[163,260],"increased":[165],"84.1":[167],"13.7":[169],"84.4":[171],"13.3":[173],"group.":[178],"versus":[180,202,214,227],"induced":[182],"changes":[183],"baseline":[185,238],"endpoint":[187],"fasting":[189,306],"(nmol/L),":[191],"proinsulin":[192,309,322],"levels":[195],"(pmol/L)":[196],"-":[198,203,210,215,223],"0.2":[199],"0.1":[204],"0.6":[206],"0.04),":[209],"11.2":[211],"26.0":[213],"17.3":[218],"0.03),":[221],"27.8":[224],"147.4":[226],"+":[228],"32.6":[229],"286.2":[231],"(not":[232],"significant),":[233],"respectively.":[234],"HbA":[235],"1c":[236],"7.5":[240],"%":[243,250],"7.7":[247],"did":[254],"not":[255],"change":[256],"significantly":[257],"either":[259],"during":[261],"investigation.":[263],"No":[264],"significant":[265],"difference":[266],"observed":[268],"between":[269],"groups":[271],"respect":[273],"hypoglycemic":[275,293],"episodes.":[276,294],"Treatment":[277],"improved":[280,321],"postprandial":[281],"control":[284],"more":[285],"than":[286],"without":[288],"increasing":[289],"body":[290],"addition,":[296],"use":[297],"associated":[301],"decrease":[304],"levels,":[310],"suggesting":[311],"potential":[313],"down":[314],"regulation":[315],"endogenous":[317],"production":[319],"processing":[323],"efficiency.":[324]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}